Please wait

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Name of Issuer)

(Title of Class of Securities)

(CUSIP Number)

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13D/A 0000902664-23-005128 0001786767 XXXXXXXX LIVE 1 Ordinary Shares, no par value per share 02/04/2026 false 0001764046 G21810109 CLARIVATE PLC 4TH FLOOR, ST. PAUL'S GATE 22-24 NEW STREET ST. HELIER Y9 JE14TR Lauren Taylor Wolfe 212-218-8810 Impactive Capital LP 450 West 14th Street, 12th Floor New York NY 10014 Christain Asmar 212-218-8810 Impactive Capital LP 450 West 14th Street, 12th Floor New York NY 10014 Ele Klein & Adriana Schwartz (212) 756-2000 McDermott Will & Schulte LLP 919 Third Avenue New York NY 10022 0001786767 N Impactive Capital LP b AF N DE 0.00 23021664.00 0.00 23021664.00 23021664.00 N 3.5 IA PN 0001786731 N Impactive Capital LLC b AF N DE 0.00 23021664.00 0.00 23021664.00 23021664.00 N 3.5 OO 0001699118 N Lauren Taylor Wolfe b AF N X1 0.00 23021664.00 0.00 23021664.00 23021664.00 N 3.5 IN 0001787532 N Christian Asmar b AF N X1 0.00 23021664.00 0.00 23021664.00 23021664.00 N 3.5 IN Ordinary Shares, no par value per share CLARIVATE PLC 4TH FLOOR, ST. PAUL'S GATE 22-24 NEW STREET ST. HELIER Y9 JE14TR The following constitutes Amendment No. 1 ("Amendment No. 1") to the Schedule 13D filed with the Securities and Exchange Commission (the "SEC") on October 16, 2023 (as amended, the "Schedule 13D"). This Amendment No. 1 amends and restates Items 3 and 5(a)-(c) and (e) as set forth below. Capitalized terms used herein and not otherwise defined in this Amendment No. 1 have the meanings set forth in the Schedule 13D. The Shares reported herein were purchased with working capital of the Impactive Funds (which may, at any given time, include margin loans made by brokerage firms in the ordinary course of business) in open market purchases. An aggregate of approximately $146,406,907, including brokerage commissions, was used to acquire the Shares reported herein. See rows (11) and (13) of the cover pages to this Schedule 13D for the aggregate number of Shares and percentage of Shares beneficially owned by each Reporting Person. The aggregate percentage of Shares reported to be beneficially owned by each Reporting Person is based upon 661,435,069 Shares outstanding as of September 30, 2025, as disclosed in the Issuer's Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2025, filed with the SEC on October 29, 2025. See rows (7) through (10) of the cover pages to this Schedule 13D for the number of Shares as to which each Reporting Person has the sole or shared power to vote or direct the vote and sole or shared power to dispose or to direct the disposition. The transactions in the Shares effected by the Reporting Persons during the past sixty (60) days are set forth on Schedule A attached hereto and incorporated by reference herein. February 4, 2026. Impactive Capital LP /s/ Lauren Taylor Wolfe By: Impactive Capital LLC, General Partner, By: Lauren Taylor Wolfe, Managing Member 02/06/2026 Impactive Capital LLC /s/ Lauren Taylor Wolfe Lauren Taylor Wolfe, Managing Member 02/06/2026 Lauren Taylor Wolfe /s/ Lauren Taylor Wolfe Lauren Taylor Wolfe, Individually 02/06/2026 Christian Asmar /s/ Christian Asmar Christian Asmar, Individually 02/06/2026